Cargando…
Dysregulation of FBW7 in malignant lymphoproliferative disorders
The ubiquitin-proteasome system (UPS) is involved in various aspects of cell processes, including cell proliferation, differentiation, and cell cycle progression. F-box and WD repeat domain-containing protein 7 (FBW7), as a key component of UPS proteins and a critical tumor suppressor in human cance...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707496/ https://www.ncbi.nlm.nih.gov/pubmed/36457505 http://dx.doi.org/10.3389/fonc.2022.988138 |
_version_ | 1784840715204820992 |
---|---|
author | Wan, Xin Guo, Wei Zhan, Zhumei Bai, Ou |
author_facet | Wan, Xin Guo, Wei Zhan, Zhumei Bai, Ou |
author_sort | Wan, Xin |
collection | PubMed |
description | The ubiquitin-proteasome system (UPS) is involved in various aspects of cell processes, including cell proliferation, differentiation, and cell cycle progression. F-box and WD repeat domain-containing protein 7 (FBW7), as a key component of UPS proteins and a critical tumor suppressor in human cancers, controls proteasome-mediated degradation by ubiquitinating oncoproteins such as c-Myc, Mcl-1, cyclin E, and Notch. It also plays a role in the development of various cancers, including solid and hematological malignancies, such as T-cell acute lymphoblastic leukemia, diffuse large B-cell lymphoma, and multiple myeloma. This comprehensive review emphasizes the functions, substrates, and expression of FBW7 in malignant lymphoproliferative disorders. |
format | Online Article Text |
id | pubmed-9707496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97074962022-11-30 Dysregulation of FBW7 in malignant lymphoproliferative disorders Wan, Xin Guo, Wei Zhan, Zhumei Bai, Ou Front Oncol Oncology The ubiquitin-proteasome system (UPS) is involved in various aspects of cell processes, including cell proliferation, differentiation, and cell cycle progression. F-box and WD repeat domain-containing protein 7 (FBW7), as a key component of UPS proteins and a critical tumor suppressor in human cancers, controls proteasome-mediated degradation by ubiquitinating oncoproteins such as c-Myc, Mcl-1, cyclin E, and Notch. It also plays a role in the development of various cancers, including solid and hematological malignancies, such as T-cell acute lymphoblastic leukemia, diffuse large B-cell lymphoma, and multiple myeloma. This comprehensive review emphasizes the functions, substrates, and expression of FBW7 in malignant lymphoproliferative disorders. Frontiers Media S.A. 2022-11-09 /pmc/articles/PMC9707496/ /pubmed/36457505 http://dx.doi.org/10.3389/fonc.2022.988138 Text en Copyright © 2022 Wan, Guo, Zhan and Bai https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Wan, Xin Guo, Wei Zhan, Zhumei Bai, Ou Dysregulation of FBW7 in malignant lymphoproliferative disorders |
title | Dysregulation of FBW7 in malignant lymphoproliferative disorders |
title_full | Dysregulation of FBW7 in malignant lymphoproliferative disorders |
title_fullStr | Dysregulation of FBW7 in malignant lymphoproliferative disorders |
title_full_unstemmed | Dysregulation of FBW7 in malignant lymphoproliferative disorders |
title_short | Dysregulation of FBW7 in malignant lymphoproliferative disorders |
title_sort | dysregulation of fbw7 in malignant lymphoproliferative disorders |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707496/ https://www.ncbi.nlm.nih.gov/pubmed/36457505 http://dx.doi.org/10.3389/fonc.2022.988138 |
work_keys_str_mv | AT wanxin dysregulationoffbw7inmalignantlymphoproliferativedisorders AT guowei dysregulationoffbw7inmalignantlymphoproliferativedisorders AT zhanzhumei dysregulationoffbw7inmalignantlymphoproliferativedisorders AT baiou dysregulationoffbw7inmalignantlymphoproliferativedisorders |